本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

Madrigal Pharmaceuticals, Inc.

311.14
-8.7300-2.73%
盘前306.14-5.0000-1.61%04:22 EDT
成交量:27.41万
成交额:8,517.73万
市值:69.08亿
市盈率:-17.32
高:322.50
开:322.50
低:307.43
收:319.87
数据加载中...
2025/06/20

员工持股计划

Form S-8 - Securities to be offered to employees in employee benefit plans
2025/06/20

重要事件披露

Form 8-K - Current report
2025/05/01

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2025/05/01

重要事件披露

Form 8-K - Current report
2025/04/17

重要事件披露

Form 8-K - Current report
2025/03/13

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/03/12

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/03/11

重要事件披露

Form 8-K - Current report
2025/03/05

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/03/03

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/03/03

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/03/03

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/02/28

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/02/28

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/02/27

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/02/26

年度报告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2025/02/26

重要事件披露

Form 8-K - Current report
2025/01/24

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/01/24

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/01/24

关联方拟减持公告

Form 144 - Report of proposed sale of securities